Dr Xiaoying Chen is a Heart Foundation Postdoctoral Fellow and a Senior Research Fellow in the Brain Health Program at the George Institute for Global Health. She leads the stroke and technology themes in the Brain Health Program at the George Institute. She has 20 years’ experience in international multicenter clinical trials and 16 years in designing and conducting large international clinical trials. She has led and been pivotal to the success of multiple international randomised controlled trials which have had significant impact on guidelines, and decision-making in clinical practice. Dr Chen has vast experience in large scale stroke trials and has been pivotal to the success of multiple world-class large international clinical trials, including as one of the Lead PIs of A multi-faCtorial, mulTi-arm, multi-staGe, randomised, gLOBal Adaptive pLatform trial for stroke (ACT-GLOBAL) aiming to be executed through 300+ hospitals in 20+ countries, Global Project Lead of landmark trials, including INTERACT3, INTERACT4, ENCHANTED2, ENCHANTED, and INTERACT2. Her research program focuses on treatment in acute stroke care and stroke recovery by designing and implementing innovative large international clinical trials, developing new tools and measures to support stroke care, especially for remote and underserved population.